New Web Tool Fights Antibacterial Resistance

In 1943, two scientists named Max Delbrück and Salvador Luria conducted an experiment to show that bacteria can mutate randomly, independent of external stimulus, such as an antibiotic that threatens a bacterial cells' survival. Today the Luria-Delbrück experiment is widely used in laboratories for a different purpose - scientists use this classic experiment to determine microbial mutation rates. When performing the Luria-Delbrück experiment, scientists need efficient computer algorithms to extract reliable estimates of mutation rates from data, and they also need well-designed software tools to access these sophisticated algorithms.

Through the years, several web tools that allow researchers to more easily input and analyze data on a computer were developed to increase efficiency and efficacy of the Luria-Delbrück experiment. However, no existing web tool allows scientists to access many recently developed algorithms that can extract even more accurate estimates of microbial mutation rates from data.

Qi Zheng, PhD, professor at the Texas A&M University School of Public Health, recently developed a new web tool called webSalvador to fill several gaps left by existing web tools. In the Microbiology Resource Announcements (MRA) Journal, Zheng explains how WebSalvador offers many desirable capabilities that are vital to bacteria mutation research, including more accurate methods for constructing confidence intervals and new methods for comparing mutation rates.

The web tool also eliminates the need for scientists to learn programming and software language, which Zheng described as an "important barrier" to using the Luria-Delbrück experiment to tackle important problems in mutation research, such as the global public health headache of bacterial drug resistance.

"Learning software languages can be challenging and time consuming for most biologists," Zheng said. "With webSalvador, biologists can input data and see results easily."

Increasing the efficiency and efficacy of the Luria-Delbrück experiment is important because it can ultimately help advance mutation research, which is vital to many branches of life sciences. Zheng cites bacterial drug resistance as one of the most important applications of the Luria-Delbrück experiment, and refers to multi-drug resistant tuberculosis as an example in which advanced mutation research is vital. He calls microbial drug resistance a "wide-spread, global health problem."

Zheng Q.
webSalvador: a Web Tool for the Luria-Delbrük Experiment.
Microbiol Resour Announc. 2021 May 20;10(20):e00314-21. doi: 10.1128/MRA.00314-21

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...